Name of the Procedure:

Common name(s): Formoterol Fumarate Inhalation Solution
Technical/Medical term: Formoterol fumarate, inhalation solution, FDA approved final product, non-compounded, administered through durable medical equipment (DME), unit dose form, 20 micrograms (HCPCS Code J7606).

Summary

Formoterol fumarate inhalation solution is a medication used to help make breathing easier for patients with chronic respiratory conditions. This solution is administered via a nebulizer, a device that turns liquid medicine into a mist that can be inhaled directly into the lungs.

Purpose

The primary purpose is to manage chronic respiratory diseases like Chronic Obstructive Pulmonary Disease (COPD) and asthma. The medication helps by dilating the airways, reducing symptoms like shortness of breath, wheezing, and chronic cough. The goal is to enhance the patient's quality of life by improving lung function and minimizing breathing difficulties.

Indications

• Chronic Obstructive Pulmonary Disease (COPD)
• Asthma
• Chronic Bronchitis
• Emphysema
• Patients experiencing frequent or severe respiratory symptoms not adequately managed by other medications

Preparation

• No specific fasting or dietary restrictions are needed.
• Patients should inform their healthcare provider about any other medications they are taking, including over-the-counter drugs and supplements.
• A spirometry test may be conducted to assess lung function before starting the treatment.

Procedure Description

1. The patient will use a nebulizer, a medical device that turns liquid medication into a fine mist.
2. Measure one unit dose of Formoterol fumarate (20 micrograms) and place it in the nebulizer.
3. The patient will attach the nebulizer to a power source and to the mouthpiece or face mask.
4. The patient will inhale the medication slowly and deeply until all of the liquid has been aerosolized.
5. The process usually takes about 5 to 10 minutes.
6. After inhalation, the patient should rinse their mouth with water to prevent infections or irritation.

Duration

The nebulization process typically takes around 5 to 10 minutes per session.

Setting

This procedure is generally performed at home, but initial administration and instruction are often done in a clinic or hospital.

Personnel

The primary oversight is by the prescribing healthcare provider, typically a pulmonologist or primary care physician. Initial instruction may involve a respiratory therapist or nurse who demonstrates how to use the nebulizer.

Risks and Complications

• Common risks: mild throat irritation, dry mouth, or cough post-inhalation
• Rare risks: paradoxical bronchospasm, increased heart rate, or palpitations
• Management: any severe reactions should be reported to a healthcare provider immediately

Benefits

• Improved lung function
• Relief from respiratory symptoms like shortness of breath and wheezing
• Enhanced quality of life and ability to perform everyday activities
• Benefits can be noticed within minutes, but maximum effectiveness may take a few weeks of consistent use.

Recovery

• No downtime required
• Patients can resume normal activities immediately after the administration
• Regular follow-up appointments for monitoring lung function and symptoms
• Continue maintenance therapy as prescribed

Alternatives

• Other bronchodilators (e.g., Albuterol)
• Inhaled corticosteroids
• Combination inhalers (e.g., fluticasone/salmeterol)
• Pros: Some alternatives might provide faster relief for acute symptoms.
• Cons: Alternatives may have different side effects or may not be as effective in treating chronic conditions.

Patient Experience

• The patient may feel a slight cool mist while inhaling the medication.
• Minimal discomfort, with possible mild throat irritation or dry mouth.
• Effective pain management and comfort measures include proper hydration and using the nebulizer as instructed.